Evidence map›Paper›PMID 34647441›Full record

ArticleHaematologica2022

Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia.

Steven Goossens, Anje Cauwels, Tim Pieters, Renate De Smedt, Sara T'Sas, André Almeida, Willem Daneels, Pieter Van Vlierberghe, Jan Tavernier

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Steven GoossensCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Diagnostic Sciences, Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent.
Anje CauwelsCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent, Belgium; VIB-UGent Center for Medical Biotechnology, B-9000 Ghent, Belgium; Orionis Biosciences BV, B-9052 Ghent.
Tim PietersCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent.
Renate De SmedtCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent.
Sara T'SasCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent.
André AlmeidaCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent.
Willem DaneelsCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Hematology, Ghent University Hospital, B-9000 Ghent.
Pieter Van VlierbergheCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent. pieter.vanvlierberghe@ugent.be.
Jan TavernierCancer Research Institute Ghent (CRIG), Ghent University, B-9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, B-9000 Ghent, Belgium; VIB-UGent Center for Medical Biotechnology, B-9000 Ghent, Belgium; Orionis Biosciences BV, B-9052 Ghent.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

InterferonsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaHumansT-LymphocytesInterferons

Identifiers

PMID34647441
PMCPMC9152961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.